Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins

Nonfiction, Health & Well Being, Medical, Medical Science, Immunology, Pharmacology
Cover of the book Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319468778
Publisher: Springer International Publishing Publication: April 7, 2017
Imprint: Springer Language: English
Author:
ISBN: 9783319468778
Publisher: Springer International Publishing
Publication: April 7, 2017
Imprint: Springer
Language: English

This book describes the newest developments in antibody drug conjugates and immunotoxins, paving their way to clinical application. Lessons learned from the current state of the art are used to further improve our understanding of their mechanisms of action and off target activities.

The book introduces scientists to all of the prerequisites that must be properly addressed, including identification of the right target, specific traits of target binding antibodies, proper selection of the toxic payload, internalization induced by binding, and next generation conjugation and linker technologies. These knowledge-based, revolutionary new drug principles will form the cornerstone of the future standard of care and will lead to major advances in application, as well as improved quality of life and patient survival rates. This book will be of interest to biotech companies and researchers working in the fields of immunology, pharmacology, and oncology.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This book describes the newest developments in antibody drug conjugates and immunotoxins, paving their way to clinical application. Lessons learned from the current state of the art are used to further improve our understanding of their mechanisms of action and off target activities.

The book introduces scientists to all of the prerequisites that must be properly addressed, including identification of the right target, specific traits of target binding antibodies, proper selection of the toxic payload, internalization induced by binding, and next generation conjugation and linker technologies. These knowledge-based, revolutionary new drug principles will form the cornerstone of the future standard of care and will lead to major advances in application, as well as improved quality of life and patient survival rates. This book will be of interest to biotech companies and researchers working in the fields of immunology, pharmacology, and oncology.

More books from Springer International Publishing

Cover of the book Theory of Hematopoiesis Control by
Cover of the book Advanced Microscopy in Mycology by
Cover of the book Third Party Sex Work and Pimps in the Age of Anti-trafficking by
Cover of the book Mycoremediation and Environmental Sustainability by
Cover of the book Neoliberal Bio-Economies? by
Cover of the book Eigenvalue Problems: Algorithms, Software and Applications in Petascale Computing by
Cover of the book Electric Fields, Additives and Simultaneous Heat and Mass Transfer in Heat Transfer Enhancement by
Cover of the book Electricity Markets with Increasing Levels of Renewable Generation: Structure, Operation, Agent-based Simulation, and Emerging Designs by
Cover of the book Intelligent Comparisons: Analytic Inequalities by
Cover of the book Leading Successfully in Asia by
Cover of the book Sigma Receptors: Their Role in Disease and as Therapeutic Targets by
Cover of the book Solar Photovoltaic System Applications by
Cover of the book The Social Neuroscience of Intergroup Relations: by
Cover of the book Technoscience and Citizenship: Ethics and Governance in the Digital Society by
Cover of the book Chronic Illness Care by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy